The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EBMT 2019 | Education initiatives for CAR T-cell therapy
In this video, John Murray, RGN, of Christie Hospital NHS Foundation Trust, Manchester, UK, speaks about the educational initiatives for novel therapies, in particular, the novel cellular therapy of CAR T-cells. Mr Murray also discusses the role of nurses in the management of patients with CAR T-cell therapy, emphasizing they are at the frontline and are the first member of staff that come into close contact with the patient. Recorded at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.
